Delivery Order SPE2DB20D7066-SPE2DB25FC4VS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) with a ceiling value of $1,366.30. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. The order is expected to be completed by August 18, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,963.54 to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packages) with a completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) valued at $1,875.80. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order will be fulfilled from the vendor's corporate...
- The Defense Logistics Agency awarded a $1,722.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) under contract number 4568916705. The order, placed without a set-aside designation, was competitively awarded and completed on July 29, 2025, with an ultimate completion date of July 30, 2025. Performance of this delivery order is based in Conshohocken, Pennsylvania, the company's corporate headquarters location....
- The Defense Logistics Agency awarded a delivery order valued at $2,286.11 to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 26, 2025, with an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) with a ceiling value of $5,258.67. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loryna 3 mg-0.02 mg tablets in quantities of 28 with a ceiling value of $9,337.76. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,762.17, is for the delivery of Loryna 3 mg-0.02 mg tablets. The award has an ultimate completion date of May 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,879.93 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loryna 3-0.02mg contraceptive medication (84 tablets). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract vehicle. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $531 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562145815 LORYNA 3 MG-0.02 MG TABLETS. The order is to provide 28S of the product and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania between September 12-13, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve as the prime contractor. No subcontractors or set aside designations...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4VSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packages) under a firm fixed-price contract with a ceiling value of $5,381.36. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp has demonstrated consistent capability in fulfilling federal medical procurement requirements through competitive awards covering diverse pharmaceutical products and therapeutic domains across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/18/25 |